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Letters to the Editor 1141enough data about CMR for inflammation evaluation in KD. Our
findings were in agreement with previous clinical studies supporting
the high incidence of myocarditis during stages II and III (days 12
to 25 and days 25 to 40, respectively) and in older patients. In our
patients with myocardial inflammation, both T2-weighted analysis
and EGE were highly suggestive of inflammatory process. The lack
of LGE in one-half of the patients was not a surprising finding. In
contrast to viral myocarditis, which is considered to be the result of
injury by virus infiltration and the host’s immune response, the
myocarditis in KD is characterized by inflammatory infiltration
from the coronary arteries to the interstitial myocardium, and
therefore the myocardial necrosis is not observed frequently, which
may explain the lack of LGE and the rapid clinical improvement of
our cases (5).
Another important finding was the presence of ectasia, but not
aneurysm, in all KD patients. This is probably because the early
administration of immunoglobulin decreased the incidence of
coronary aneurysms (1). However, myocardial inflammation was a
common finding, with rapid recovery in the subsequent 3 months.
The current study has the following limitations: 1) the small
number of patients, older than the usual age for KD; 2) infants with
severe myocardial disease were not included; 3) long-term CMR
follow-up was not available; and 4) myocardial biopsy was not
available because of the benign presentation of the disease, which
did not allow an invasive procedure.
In conclusion, coronary ectasia and myocardial inflammation are
common findings during the convalescence of KD, but usually have
a benign prognosis. Myocardial infarction and coronary aneurysms
occasionally can be found, although immunoglobulin was admin-
istered during the early phase of the disease. A single comprehen-
sive CMR examination applied in KD during convalescence may
provide important diagnostic information on myocardial inflamma-
tion and coronary anatomy, and thus may be helpful for therapeutic
decision making. However, further studies are needed to confirm
Figure 2. Viability Image
Viability image showing a transmural, inferior myocardial infarction (arrow)
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Prosthetic Heart Valve
Ring Thrombosis
Despite being mechanical and prosthetic, heart valve rings (HVR) are
known to have a lower risk of thrombosis compared with prosthetic
mechanical heart valves, thus anticoagulation therapy is only recom-
mended within 3 months after the surgery according to the current
guidelines (1). We present 4 cases in whichHVR thrombi were obtained
by transesophageal echocardiography (TEE) as a novel finding with
HVR.
The first case was a 41-year-old woman who had a mitral HVR
operation 3 months before her admission with acute atrial fibrillation
and who was a candidate for electrical cardioversion. She was referred for
TEE to exclude the presence of left atrial (LA) thrombus when we
incidentally observed multiple hyperechogenic, mobile thrombus images
on the prostheticmitral ring (Sorin ring, number: 34, SorinGroup,Milan,
Italy) (Fig. 1A, Online Video 1A). Her international normalized ratio
(INR) was effective (2.6) on admission. As a result of having a history of
embolic stroke 1 year previously, the patient was given a low-dose (25mg),
slow-infusion (6 h) tissue-type plasminogen activator (TPA)without bolus
administration 2 times (for a total of 50mg), and as a result, TEE showed
an unsatisfactory regression in the thrombi (Fig. 1B, Online Video 1B).
We decided to follow up the patient under effective anticoagulation
because she refused both the repeat dose of TPA and choice of surgery.
The second case was a 61-year-old woman who had mitral valve
replacement (ATS, number: 27, ATS Medical, Inc., Minneapolis, Min-
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Letters to the Editor1142nesota) and tricuspid valve annuloplasty (Sorin ring, number: 34, Sorin
Group) operation 3 months before her admission with progressive severe
dyspnea. TEE revealed 3 big nonobstructive thrombi (2.9 1.0 cm, 2.4
 1.3 cm, and 1.2  0.8 cm, respectively) over the prosthetic tricuspid
ring, which were relocating from right atrium to right ventricle in every
diastole (Fig. 1C,Online Video 1C). Because she had elevated pulmonary
artery pressure (PAP) (60mmHg), we also performed thoracic computed
tomography for a suspected pulmonary embolism, but the pulmonary
arteries were clear of thrombus. It was surprising to obtain thrombus on
the tricuspid ring despite having effective INR levels (3.4) and a mechan-
ical prosthetic mitral valve clear of thrombus. Because the thrombi were
big and extremely mobile, the patient was considered to be high risk and
was offered surgery. Because she refused the operation, again low-dose,
slow-infusion TPAwas performed 3 times (for a total of 75 mg). Control
TEE revealed minimal regression in the thrombus sizes (Fig. 1D, Online
Video 1D). The patient refused further treatment andwas dischargedwith
effective-dose anticoagulation.
The third case was a 40-year-old asymptomatic woman who was
admitted for routine echocardiographic examination 3months after having
aortic andmitral valve replacement and a tricuspid annuloplasty operation.
After obtaining suspected thrombus images on tricuspid ring in transtho-
racic echocardiography, we observed 2 hyperechogenic, mobile masses
(1.5 0.8 cm and 0.78 0.5 cm in size) over the tricuspid annuloplasty
ring (Sorin ring, number: 34, Sorin Group) causing a 2.8 mm Hg
transtricuspid gradient in TEE examination (Fig. 2A, Online Video 2A).
Figure 1. TEE Findings of 2 Patients With HVR
(A) A 41-year-old woman with multiple hyperechogenic, mobile thrombi (arrows) o
An unsatisfactory regression in the thrombus size (arrows) after thrombolytic thera
cm, 2.4  1.3 cm, and 1.2  0.8 cm, respectively) over the tricuspid annuloplasty r
Control TEE images showing minimal regression in the thrombus sizes (arrows) aft
tic valve; HVR  heart valve rings; LA  left atrium; LV  left ventricle; MV  mitrDespite having an ineffective INR (1.68) this time, similar to the secondcase, both the mechanical prosthetic mitral and aortic valves were free of
thrombus. Because the thrombi were obstructive, we performed low-dose,
slow-infusion TPA 2 times (for a total of 50 mg), and significant
regression in both thrombi sizes and transtricuspid gradient (1.2 mmHg)
was provided (Fig. 2B, Online Video 2B).
The last case was a 68-year-old man who presented with acute
pulmonary edemawith a history of coronary artery bypass graft surgery and
mitral annuloplasty (Sorin ring, number: 32, Sorin Group) 1 year previ-
ously. TEE revealed an obstructive 1.16  0.7 cm, hyperechogenic,
mobile mass over the prosthetic mitral ring causing an 11.8 mmHgmean
transmitral gradient and elevated PAP (65 mm Hg) (Fig. 2C, Online
Video 2C).Hewas on anticoagulation therapy due to atrial fibrillation, but
his INR (1.5) was ineffective. Because of the obstructive pattern of the
thrombus, we administrated low-dose, slow-infusion TPA 3 times (for a
total of 75 mg) in this case. Thrombus seemed to be smaller, but the
transmitral gradient was still high (8.9 mm Hg) (Fig. 2D, Online
Video 2D). Because the patient rejected the surgical option, we
decided to follow him up under effective anticoagulation. One year
later, he was re-admitted to our hospital with acute pulmonary
edema again caused by an obstructive mitral ring thrombus; he
urgently underwent cardiac surgery and had a successful clinical
outcome.
These cases are interesting because 2 of them were asymptomatic and
were incidentally diagnosed, whereas 3 of the patients were diagnosed
within 3 months after the annuloplasty operation, such that they were still
on anticoagulation. Having thrombus-free prosthetic valves in 2 of the
e prosthetic mitral ring in transesophageal echocardiographic (TEE) imaging. (B)
observed. (C) A 61-year-old woman with 3 huge thrombi (arrows) (2.9  1.0
which were relocating from right atrium to right ventricle in every diastole. (D)
ministrating thrombolytic treatment. See Online Video 1. AO  aorta; AV  aor-
lve; TRB  thrombus; TV Ring  tricuspid valve ring.n th
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Letter to the Editor 1143ing.We think that more attention should be paid to prosthetic heart valve
rings because of their potential for the increased risk of thrombosis.
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For supplemental videos, please see the online version of this paper.
Does Low Pre-Test Probability of
Coronary Artery Disease Reﬂect
Overuse of Stress Testing?
Chen et al. (1) describe few differences in downstream use of
cardiovascular procedures between office- and hospital-based car-
Figure 2. HVR Thrombosis Images by TEE
(A) A 40-year-old asymptomatic woman with hyperechogenic, mobile masses (a
ring in TEE examination. (B) A complete resolution was revealed after the throm
a 68-year-old man with a 1.16  0.7 cm, hyperechogenic, mobile mass (arrow)
Hg. (D) Despite regression of the thrombus size (arrow), the transmitral gradien
Video 2. MV Ring  mitral valve ring; RA  right atrium; other abbreviations asdiovascular stress testing. Despite the similarities between the 2 croups, we are struck by low post-test rates of cardiac catheteriza-
ion: 7 of 8 patients who underwent myocardial perfusion
maging and 13 of 14 patients who underwent stress echocardi-
graphy did not undergo cardiac catheterization (or revasculariza-
ion) within the next 6 months. We argue that these low rates
eflect overuse of stress testing in both groups, due at least in part
o inappropriate testing of lower pre-test probability patients, even
ith a 26% prevalence of coronary artery disease.
We performed estimates of pre-test probabilities with: 1) rates of
ardiac catheterization reported by Chen et al. (1) as a ceiling of
ost-test probability; and 2) likelihood ratios (LRs) based on
ublished sensitivity/specificity estimates of myocardial perfusion
maging (LR  3.2 to 3.6) (2) and stress echocardiography (LR 
.7 to 7.1) (3). We estimate that the mean pre-test probability of
aving ischemic heart disease in this cohort averages only 1.5% to
.9%.
American College of Cardiology/American Heart Association
uidelines recommend exercise stress testing individuals with in-
ermediate pre-test probabilities of ischemic heart disease, as
efined by age, sex, and symptoms (4). For comparison of expected
ardiac catheterization rates, we estimated post-test probabilities of
hypothetical intermediate risk cohort of 50- to 59-year-old
ubjects with chest pain with an adjusted Diamond-Forrester model
5) and conservative LR  3.4. We estimate a post-test probability
f coronary artery disease (as cardiac catheterization estimate/
eiling) of 63% to 76% in men and 31% to 75% in women,
w) (1.5  0.8 cm and 0.78  0.5 cm in size) over the tricuspid annuloplasty
lytic therapy with tissue-type plasminogen activator (arrow). (C) TEE images of
r the prosthetic mitral valve ring with a transmitral mean gradient of 11.8 mm
as found to be still high (8.9 mm Hg) in control TEE examination. See Online
Figure 1.rro
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inompared with rates of 5% to 12% in Chen et al. (1).
